Allogene Therapeutics, Inc. (ALLO) vs TRex Bio Inc. (TRXB)

Allogene Therapeutics, Inc. ALLO 1.04 −4.59%
TRex Bio Inc. TRXB 13.26 +2.08%

Allogene Therapeutics, Inc. and TRex Bio Inc. are both Biotechnology companies. Allogene Therapeutics, Inc. and TRex Bio Inc. are of similar size ($376.6M and $356.5M).

Metric	ALLO	TRXB	Biotechnology median
P/E	n/m	—	10.60
P/S	72.71	—	9.40
P/B	0.78	—	2.13
Price to free cash flow	n/m	—	25.18
EV/EBITDA	n/m	—	0.66
EV/Sales	2.02	—	9.02
Earnings yield	(64.42%)	—	(32.88%)
Free cash flow yield	(29.99%)	—	(23.13%)

Metric	ALLO	TRXB	Biotechnology median
Gross margin	100.00%	—	68.51%
Operating margin	(3,832.45%)	—	0.00%
Net margin	(3,517.41%)	—	0.00%
Free cash flow margin	(2,180.62%)	—	0.00%
Return on equity	(42.39%)	—	(51.96%)
Return on assets	(32.43%)	—	(46.06%)
Return on invested capital	(108.81%)	—	0.00%

Metric	ALLO	TRXB	Biotechnology median
Revenue growth (TTM)	7,613.11%	—	6.76%
EPS growth (last fiscal year)	34.09%	—	29.88%
Revenue growth, 5-year CAGR	—	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	ALLO	TRXB	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	10.72	—	4.97
Net debt to EBITDA	1.24	—	1.01

Metric	ALLO	TRXB	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	ALLO	TRXB	Biotechnology median
Market cap	376.58m	356.52m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack